Welcome to our dedicated page for AMES National news (Ticker: ATLO), a resource for investors and traders seeking the latest updates and insights on AMES National stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AMES National's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AMES National's position in the market.
Ames National Corporation (Nasdaq: ATLO) reported a net income of $4.4 million ($0.49 per share) for Q4 2022, down from $5.3 million ($0.58 per share) in Q4 2021. Total net income for 2022 was $19.3 million ($2.14 per share), a decline from $23.9 million ($2.62 per share) in 2021. Key factors included increased interest expenses on deposits and reduced Paycheck Protection Program fees. The net interest margin decreased to 2.45% from 2.65% year-over-year. Total assets were $2.13 billion with a slight decline from 2021. The company forecasts 2023 earnings between $1.75 and $1.85 per share, reflecting inflation and higher interest expenses.
FAQ
What is the current stock price of AMES National (ATLO)?
What is the market cap of AMES National (ATLO)?
